{
  "contract_version": "supplier-contract-v0.1",
  "project": "ecu-901831",
  "supplier_group_id": "BECTON_DICKINSON_INDUSTRIAS_CIRURGICAS_LTDA",
  "generated_at": "2026-04-17T02:13:17.491Z",
  "model": "gpt-4.1-mini",
  "provider_stack": [
    "openai"
  ],
  "narratives": {
    "positioning_summary": "BECTON DICKINSON 是巴西来源的 Tier A 区域分销商，在 2010–2015 年数据期内占据 12.84% 的市场份额，排名第三。",
    "buyer_strategy": "海外买家结构高度集中，Top1 买家 IMPORTADORA BOHORQUEZ C. LTDA. 独占 72.0% 份额，意味着替代难度极大，需先攻克其头部客户或等待其流失。",
    "pricing_read": "其加权均价为$0.1715/unit，比市场均价$0.1022/unit 高出 67.8%，主战场在$0.0200–$0.1050 这一占 74.8% 份额的低价带，建议从该档切入。",
    "trend_read": "该供应商 CAGR 为 -2.7%，末年出货额仅为峰值的 87%，且海外买家净减 1 家（新增 3 家，流失 4 家），处于退场阶段。",
    "competitive_angles": {
      "strengths": [
        "Top1 买家 IMPORTADORA BOHORQUEZ C. LTDA. 贡献 72.0% 营收",
        "出货批次达 204 批，历史数据覆盖 6 年",
        "在$0.0200–$0.1050 低价带占据 74.8% 份额"
      ],
      "weaknesses": [
        "价格显著高于市场均价，溢价 67.8%",
        "海外买家净流失 1 家，趋势下滑",
        "Top1 买家依赖度过高，抗风险能力弱"
      ],
      "how_to_attack": "优先接触流失买家 MERCK ECUADOR C.A. 或体量次大的 PHARMABRAND S.A.。报价切入$0.0200–$0.1050 低价带，避开其高价区。利用其付款方式为“无”的劣势，提供现结或更优港口 GUAYAQUIL MARITIMO 的交付条件。"
    },
    "buyer_opportunities": [
      {
        "buyer": "MERCK ECUADOR C.A.",
        "angle": "流失",
        "action": "本周联系该买家，报价区间$0.0200–$0.1050，强调其已接盘方 ARES URUGUAY 的替代方案。"
      },
      {
        "buyer": "PHARMABRAND S.A.",
        "angle": "Top依赖",
        "action": "本周报价$0.0200–$0.1050，利用其仅占供应商 6.4% 份额的松动空间切入。"
      },
      {
        "buyer": "PHARMABRAND",
        "angle": "Top依赖",
        "action": "本周报价$0.0200–$0.1050，针对其 1.9% 的低占比进行价格渗透。"
      },
      {
        "buyer": "MINISTERIO DE SALUD  PUBLICA",
        "angle": "流失",
        "action": "本周联系该买家，报价$0.0200–$0.1050，指出其峰值后由 BECTON DIKINSON 接盘的异常。"
      },
      {
        "buyer": "SIMED CIA. LTDA.",
        "angle": "流失",
        "action": "本周联系该买家，报价$0.0200–$0.1050，指出其峰值后由 BECTON DIKINSON 接盘的异常。"
      }
    ]
  }
}